PsyTechGlobal

📍 Toronto, Canada🗓 Founded 2019👥 3 employees💰 Last funded Jan 2021
Pharmaceutical Manufacturing🌐 psytechglobal.com
Website LinkedIn
PsyTech Global is the global industry conference platform for the new wave of psychedelic medicine. With renewed research interest in LSD, MDMA, Ketamine and psilocybin, and a growing normalization after decades of stigma, psychedelics are the next therapeutic frontier. Created by the team behind CannaTech, the PsyTech conference is poised to elevate the psychedelics conversation, foster normalization and accelerate innovation. PsyTech debuts in Tel Aviv June 14-15, and will bring together scientists, innovators, regulators, investors, and advocates from around the world to expand minds to the potential of psychedelic medicine.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in PsyTechGlobal?
PsyTechGlobal has 1 investors on record on gritt.io, including 1 early-stage backers.
When did PsyTechGlobal last raise funding?
The most recent investment in PsyTechGlobal recorded on gritt.io was in January 2021.
When was PsyTechGlobal founded?
PsyTechGlobal was founded in 2019.
What industry is PsyTechGlobal in?
PsyTechGlobal operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is PsyTechGlobal based?
PsyTechGlobal is headquartered in Toronto, Canada.